Menadiol 10mg tablets supply issue

Menadiol 10mg tablets supply issue

March 23, 2018

PSNC has become aware that Alliance Pharmaceuticals Ltd has transferred the production of its licensed Menadiol Diphosphate Tablets 10mg to another site but delays mean that it is likely to be out of stock until October 2018. To meet patient need, Alliance Pharmaceuticals Ltd are going to supply the equivalent unlicensed Menadiol Diphosphate Tablets 10mg, which will be available until the licensed product returns to stock.  The unlicensed product is available to order from Alliance Healthcare Distribution Limited.

To enable prescribers to issue EPS or paper prescriptions for the unlicensed Menadiol Diphosphate Tablets 10mg, a new listing has been created on dm+d for ‘Menadiol 10mg tablets (Special Order)’.

In order for pharmacy contractors to be paid correctly for dispensing the unlicensed Menadiol Diphosphate Tablets 10mg, prescriptions should read ‘Menadiol 10mg tablets (Special Order)’. Prescriptions ordering the licensed ‘Menadiol Diphosphate Tablets 10mg’ will for the meantime be priced by an exception handler stream as an unlicensed special. In both cases, prescriptions will need to be endorsed as per the usual endorsing guidance for unlicensed specials and imports not listed in the Drug Tariff (non-Part VIIIB) to include the following:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

Pharmacy teams are reminded to place prescriptions for unlicensed medicines in the red separators for end of month submission.

Please contact Alliance Pharma on +44 [0]1249 466966 or for further information.


Posted in:

More Latest News >

DSP Toolkit FAQs

This briefing may assist community pharmacy contractors with common frequently asked questions received by others who have already completed the...